Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-03-20Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer (FOLERO) : A Prospective Cohort Study to Determine the Effect of Frailty on Survival and to Assess Early Reversal of Temporary Intestinal Stoma
-
CLINICAL_TRIALS study record update · 2024-03-20The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-
-
CLINICAL_TRIALS study record update · 2024-03-19Development and Validation of Growth Prediction Model for Ovarian Cancer Organoids Based on Bright Field Image and Deep Learning
-
CLINICAL_TRIALS study record update · 2024-03-15Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI (Risk of Malignancy Index) and Tumor Markers Such as CA125 (Cancer Antigen 125) and HE4 (Human Epididymal Protein 4)
-
CLINICAL_TRIALS study record update · 2024-03-15A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1592 In Patients With Solid Tumors Likely to Express NaPi2b
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-13Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient (Pemb-HT)
-
CLINICAL_TRIALS study record update · 2024-03-12A Phase II Study Using the Administration of Autologous T-Cells Engineered Using the Sleeping Beauty Transposon/Transposase System to Express T-Cell Receptors Reactive Against Mutated Neoantigens in Patients With Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2024-03-12BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
-
CLINICAL_TRIALS study record update · 2024-03-12Precision Therapy for Solid Tumors: Synergistic Inhibition of Cell Proliferation and Angiogenesis Via CDK4/6 and Anti-VEGF Approach Targeting LncRNA Expression
-
CLINICAL_TRIALS study record update · 2024-03-04A Phase 1/2a Open-Label Dose Escalation and Dose Expansion Study of T3011 When Administered Intravenously as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-02-28Phase I Clinical Trial Testing the Dose Escalation and Expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration for the Management of Pleural Carcinosis
-
CLINICAL_TRIALS study record update · 2024-02-28Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology
-
CLINICAL_TRIALS study record update · 2024-02-20Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2024-02-15Clinical and Pathological Characteristics of Women With Ovarian Cancers, A National, Retrospective Cross-Sectional Study in Syria During the War
-
CLINICAL_TRIALS study record update · 2024-02-14Phase 1b/2a Study Investigating ATX-101 in Combination With Platinum-based Chemotherapy in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2024-02-14Systems-Level Capture of Family History Data to Assess Risk of Cancer
-
CLINICAL_TRIALS study record update · 2024-02-13The IIT Study of Evaluation of Platelet-coupled IL-2 Cell Injection (P-IL-2) Single Agent and With Anti-PD-1 Monoclonal Antibody on the Safety, Tolerance and Preliminary Effectiveness in Patients With Advanced Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-02-12EXemestane in Progesterone and/or Estrogen Receptor Positive Epithelial Ovarian Cancer: A Randomized Phase III Trial, EXPERT
-
CLINICAL_TRIALS study record update · 2024-02-09Exercise and Nutrition Intervention in Ovarian Cancer - Development of a Care Concept and Evaluation in Routine Clinical Practice
-
CLINICAL_TRIALS study record update · 2024-02-08Combination of the Hypomethylating Agent Decitabine and the Nuclear Export Receptor XPO-1 Inhibitor Selinexor to Reverse Platinum Resistance in Relapsed/Refractory Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2024-02-08A Multi-center, Perspective, Observational Case-control Study to Develop and Validate an Ovarian Cancer Early Detection Model Based on Peripheral Blood Multi-omic Analysis and Machine Learning
-
CLINICAL_TRIALS study record update · 2024-02-02HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
-
CLINICAL_TRIALS study record update · 2024-02-01The Effect of the "Feminine Identity Improvement Program" Based on Cognitive Behavioral and Expressive Techniques Applied to Gynecological Cancer Patients on Prolonged Grief Reactions and the "Perception of Femininity"
-
CLINICAL_TRIALS study record update · 2024-01-31Development and Validation of a Circulating Tumor DNA Detection Technique in Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2024-01-30ATP7A Transporter as Biomarker for Predicting Chemoresistance of Serous Ovarian Cancer